Experts still see some hope for Avastin in adjuvant colon cancer
02 June 2009
Malini Guha
Roche's (Genentech) Avastin (bevacizumab) may have failed in its first Phase III trial in adjuvant cancer – one of the most closely watched oncology drug trials of the year – because the duration of treatment with the VEGF-targeted therapy was not long enough, the trial's investigators told a plenary...
Please Login to read the full article.
02 June 2009
Malini Guha
Please Login to read the full article.
RELATED CONTENT
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
